Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05848817 · ClinicalTrials.gov registry record
Patient Reported Satisfaction With Contoura LASIK Utilizing the Phorcides Analytic Software
A clinical trial of Myopia, sponsored by Mann Eye Institute.
- Completed
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT05848817 is a study of Myopia that has completed, run by Mann Eye Institute. The registered enrollment target is 50 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05848817, a study of Myopia, has completed, sponsored by Mann Eye Institute.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective is to determine the percentage of subjects satisfied (Completely Satisfied or Very Satisfied) with vision after Phorcides Planned Contoura LASIK.
Conditions Studied
Interventions
- DEVICE Contoura LASIK
Study Locations (1)
Texas
- Mann Eye Institute - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-05-19 |
| Est. Completion | 2024-08-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05848817
The ClinicalTrials.gov registry entry for NCT05848817 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (81% lower). The listed sponsor is Mann Eye Institute, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 1 intervention - of which Contoura LASIK is the first listed.
NCT05848817 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05848817 about?
NCT05848817 is a clinical study titled "Patient Reported Satisfaction With Contoura LASIK Utilizing the Phorcides Analytic Software". The objective is to determine the percentage of subjects satisfied (Completely Satisfied or Very Satisfied) with vision after Phorcides Planned Contoura LASIK.
What is the current status of trial NCT05848817?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2023-05-19. Estimated completion is 2024-08-15.
What conditions does trial NCT05848817 study?
This clinical trial studies the following conditions: Myopia.
What interventions are being tested in trial NCT05848817?
The interventions under investigation include: Contoura LASIK (DEVICE).
Who is sponsoring clinical trial NCT05848817?
This trial is sponsored by Mann Eye Institute, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05848817 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Clinical Evaluation of WaveLight Plus LASIK
RECRUITING
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.